Datacheck:AXA/2025/FY/Financial supplement
| Document info | |
|---|---|
| Organization | AXA |
| Year | 2025 |
| Period | FY |
| Period label | FY25 |
| Document category | Financial supplement |
| Document name | AXA FY 2025 Financial Supplement (Excel) |
| Publication date | 2026-02-26 |
| Language | English |
| Source | Original URL |
| Archive file | .md file |
Source: AXA/2025/FY/Financial supplement (extracted at rev 23318) · data page: Data:AXA/2025/FY/Financial supplement.json. Open the source page to verify the figures below.
| Label | Line | Unit | Value | Citation | Status | Confirm | Reject | Correct |
|---|---|---|---|---|---|---|---|---|
| Gross Written Premiums & Other Revenues | Total | Group | EUR 115,524 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | P&C | Group | EUR 58,038 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Life & Health | Group | EUR 56,512 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Life | Group | EUR 37,499 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Health | Group | EUR 19,014 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Asset Management | Group | EUR 875 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Bank | Group | EUR 99 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Total | France | EUR 30,598 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Total | Europe | EUR 43,005 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Total | AXA XL | EUR 19,277 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Total | Asia, Africa & EME-LATAM | EUR 19,925 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Total | AXA IM | EUR 875 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| Gross Written Premiums & Other Revenues | Total | Transversal & Other | EUR 1,844 mn | Activity Indicators › Gross Written Premiums & Other Revenues | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Total | Group | EUR 2,233 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Life & Health | Group | EUR 2,233 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Life | Group | EUR 1,747 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Health | Group | EUR 486 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Total | France | EUR 695 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Total | Europe | EUR 578 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| IFRS17/9 New Business Value (NBV) | Total | Asia, Africa & EME-LATAM | EUR 959 mn | Activity Indicators › IFRS17/9 New Business Value (NBV) (a) | ✓ confirmed | |||
| New Business Contractual Service Margin (NB CSM) | Total | Group | EUR 2,199 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | ✓ confirmed | |||
| New Business Contractual Service Margin (NB CSM) | Life & Health | Group | EUR 2,199 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | ✓ confirmed | |||
| New Business Contractual Service Margin (NB CSM) | Life | Group | EUR 1,822 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | ✓ confirmed | |||
| New Business Contractual Service Margin (NB CSM) | Health | Group | EUR 377 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | unreviewed | |||
| New Business Contractual Service Margin (NB CSM) | Total | France | EUR 431 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | unreviewed | |||
| New Business Contractual Service Margin (NB CSM) | Total | Europe | EUR 740 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | unreviewed | |||
| New Business Contractual Service Margin (NB CSM) | Total | Asia, Africa & EME-LATAM | EUR 1,028 mn | Activity Indicators › New Business Contractual Service Margin (NB CSM) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Total | Group | EUR 49,357 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Life & Health | Group | EUR 49,357 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Life | Group | EUR 37,103 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Health | Group | EUR 12,254 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Total | France | EUR 22,858 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Total | Europe | EUR 12,651 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| Present Value of Expected Premiums (PVEP) | Total | Asia, Africa & EME-LATAM | EUR 13,847 mn | Activity Indicators › Present Value of Expected Premiums (PVEP) (b) | unreviewed | |||
| IFRS17/9 NBV Margin | Total | Group | 4.5% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| IFRS17/9 NBV Margin | Life & Health | Group | 4.5% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| IFRS17/9 NBV Margin | Life | Group | 4.7% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| IFRS17/9 NBV Margin | Health | Group | 4% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| IFRS17/9 NBV Margin | Total | France | 3% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| IFRS17/9 NBV Margin | Total | Europe | 4.6% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| IFRS17/9 NBV Margin | Total | Asia, Africa & EME-LATAM | 6.9% | Activity Indicators › IFRS17/9 NBV Margin (a)/(b) | unreviewed | |||
| Total Assets | Total | Group | EUR 636 bn | Balance Sheet › Total Assets | unreviewed | |||
| Goodwill | Total | Group | EUR 18 bn | Balance Sheet › Goodwill | unreviewed | |||
| Other intangible assets | Total | Group | EUR 4 bn | Balance Sheet › Other intangible assets | unreviewed | |||
| Shareholders' Equity group share | Total | Group | EUR 47 bn | Balance Sheet › Shareholders' Equity group share | unreviewed | |||
| Non-controlling Interests | Total | Group | EUR 2 bn | Balance Sheet › Non-controlling Interests | unreviewed | |||
| Financing debt | Total | Group | EUR 16 bn | Balance Sheet › Financing debt | unreviewed | |||
| Insurance contract liabilities | Total | Group | EUR 470 bn | Balance Sheet › Liabilities arising from insurance contracts and investment contracts with discretionary participation features contracts | unreviewed | |||
| Present Value of Future Cash Flows | Total | Group | EUR 433 bn | Balance Sheet › Liabilities › Present Value of Future Cash Flows | unreviewed | |||
| Risk Adjustment | Total | Group | EUR 3 bn | Balance Sheet › Liabilities › Risk Adjustment | unreviewed | |||
| Contractual Service Margin (closing, pre-tax) | Total | Group | EUR 33,253 mn | CSM rollforward › Total Group (pre-tax) | unreviewed | |||
| Contractual Service Margin (closing, post-tax) | Total | Group | EUR 25,864 mn | CSM rollforward › Total Group (post-tax) | unreviewed | |||
| Retained Earnings | Total | Group | EUR 41 bn | Shareholders Equity › Retained Earnings | unreviewed | |||
| Undated Subordinated Debt | Total | Group | EUR 5 bn | Shareholders Equity › Undated Subordinated Debt | unreviewed | |||
| Other Comprehensive Income | Total | Group | EUR -7 bn | Shareholders Equity › Other Comprehensive Income | unreviewed | |||
| Book Value per Share (footnote: Shareholders' equity excludes the other comprehensive income as well as the undated and deeply subordinated debt.) | Total | Group | EUR 24 | Shareholders Equity › Book Value per Share | unreviewed | |||
| Underlying Earnings Before Tax | Total | Group | EUR 11,044 mn | UE by LOB and Net Income › Underlying Earnings Before Tax | unreviewed | |||
| Underlying Earnings Group Share | Total | Group | EUR 8,368 mn | UE by LOB and Net Income › Underlying Earnings Group Share | unreviewed | |||
| Subordinated Debt Charges (post-tax) | Total | Group | EUR -174 mn | UE by LOB and Net Income › Deeply Subordinated and Undated Subordinated Debt Charges | unreviewed | |||
| Underlying Earnings for EPS | Total | Group | EUR 8,195 mn | UE by LOB and Net Income › Underlying Earnings for EPS calculation | unreviewed | |||
| Underlying Earnings Group Share | Total | Group | EUR 8,078 mn | UE by LOB and Net Income › Underlying Earnings Group Share | unreviewed | |||
| Net Income Group Share | Total | Group | EUR 9,797 mn | UE by LOB and Net Income › Net Income Group Share | unreviewed | |||
| Combined Ratio | Total | Group | 90.6% | P&C UE by Sub LOB › Combined Ratio | unreviewed | |||
| Shares Outstanding (period-end) (footnote: Under IFRS, Treasury shares are not considered as outstanding shares. Treasury shares amounted to 35 million shares as of FY25 and 39 million shares as of FY24.) | Total | Group | 2,055 mn | Shares & UEPS › As at End of Period | unreviewed | |||
| Average Shares Outstanding | Total | Group | 2,124 mn | Shares & UEPS › During the Period (A) | unreviewed | |||
| EPS | Total | Group | EUR 4.53 | Shares & UEPS › EPS (B/A) | unreviewed | |||
| Underlying EPS | Total | Group | EUR 3.86 | Shares & UEPS › Underlying EPS (C/A) | unreviewed | |||
| Net Income ROE | Total | Group | 18.8% | RoE & Gearing › Net Income ROE | unreviewed | |||
| Average Adjusted Shareholders' Equity (footnote: Excluding reserves for Other Comprehensive Income as well as undated and deeply subordinated debt (recorded through shareholders' equity).) | Total | Group | EUR 51 bn | RoE & Gearing › Average Adjusted Shareholders' Equity | unreviewed | |||
| Underlying ROE | Total | Group | 16% | RoE & Gearing › Underlying ROE | unreviewed | |||
| Debt Gearing | Total | Group | 22.3% | RoE & Gearing › Debt Gearing (G) = (B) / (E) | unreviewed | |||
| Financing Debt (senior) | Total | Group | EUR 3 bn | RoE & Gearing › Financing Debt | unreviewed | |||
| Dated Subordinated Debt | Total | Group | EUR 13 bn | RoE & Gearing › Dated Subordinated Debt | unreviewed | |||
| Eligible Own Funds | Total | Group | EUR 56 bn | Information on Solvency II › Eligible Own Fund (EOF) | unreviewed | |||
| Solvency Capital Requirement | Total | Group | EUR 25 bn | Information on Solvency II › Solvency Capital Requirement (SCR) | unreviewed | |||
| Solvency II Ratio | Total | Group | 224% | Information on Solvency II › Solvency II Ratio | unreviewed | |||
| Holdings Underlying Earnings | Total | Group | EUR -1,180 mn | Holdings › Underlying Earnings Group share | unreviewed | |||
| Closing Cash Balance at AXA SA (footnote: Includes liquid invested assets.) | Total | Group | EUR 6 bn | Holdings › Closing Cash Balance at AXA SA | unreviewed | |||
| Net cash remittance from subsidiaries (footnote: Includes exceptional cash remittances from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.4 billion in 2024) and AXA Life Europe (Euro +0.2 billion in 2024).) | Total | Group | EUR 8 bn | Holdings › Net cash remittance from subsidiaries | unreviewed | |||
| Dividends | Total | Group | EUR 5 bn | Holdings › Dividends | unreviewed | |||
| Share buy-backs (footnote: On top of annual share buy-back, includes Euro +3.5 billion share buy-back in 2025 to offset the earnings dilution resulting from the disposal of AXA IM and Euro +0.7 billion share buy-back in 2024 from the reinsurance treaties for the in-force Savings portfolio at AXA France (Euro +0.5 billion) and AXA Life Europe (Euro +0.2 billion).) | Total | Group | EUR 5 bn | Holdings › Share buy-backs | unreviewed | |||
| Insurance Revenues (P&C) | Total | Group | EUR 57,656 mn | P&C UE by Sub LOB › Revenues | unreviewed | |||
| Current Accident Year Loss Ratio | Total | Group | 66.9% | P&C UE by Sub LOB › Current Accident Year Loss Ratio | unreviewed | |||
| Prior Year Reserve Development Ratio | Total | Group | -1.1% | P&C UE by Sub LOB › Prior Year Reserve Development Ratio | unreviewed | |||
| Expense Ratio (P&C) | Total | Group | 24.8% | P&C UE by Sub LOB › Expense Ratio | unreviewed |